Insight in Hypoxia-Mimetic Agents As Potential Tools for Mesenchymal Stem Cell Priming in Regenerative Medicine

Overview

Journal Stem Cells Int

Publisher Wiley

Specialty Cell Biology

Date 2022 Apr 5

PMID 35378955

Authors

Agata Nowak-Stepniowska

Paulina Natalia Osuchowska

Henryk Fiedorowicz

Elzbieta Anna Trafny

Affiliations

Soon will be listed here.

Abstract

Hypoxia-mimetic agents are new potential tools in MSC priming instead of hypoxia incubators or chambers. Several pharmaceutical/chemical hypoxia-mimetic agents can be used to induce hypoxia in the tissues: deferoxamine (DFO), dimethyloxaloylglycine (DMOG), 2,4-dinitrophenol (DNP), cobalt chloride (CoCl), and isoflurane (ISO). Hypoxia-mimetic agents can increase cell proliferation, preserve or enhance differentiation potential, increase migration potential, and induce neovascularization in a concentration- and stem cell source-dependent manner. Moreover, hypoxia-mimetic agents may increase HIF-1, changing the metabolism and enhancing glycolysis like hypoxia. So, there is clear evidence that treatment with hypoxia-mimetic agents is beneficial in regenerative medicine, preserving stem cell capacities. These agents are not studied so wildly as hypoxia but, considering the low cost and ease of use, are believed to find application as pretreatment of many diseases such as ischemic heart disease and myocardial fibrosis and promote cardiac and cartilage regeneration. The knowledge of MSC priming is critical in evaluating safety procedures and use in clinics. In this review, similarities and differences between hypoxia and hypoxia-mimetic agents in terms of their therapeutic efficiency are considered in detail. The advantages, challenges, and future perspectives in MSC priming with hypoxia mimetic agents are also discussed.

Citing Articles

Innovative approaches to boost mesenchymal stem cells efficacy in myocardial infarction therapy.

An C, Zhao Y, Guo L, Zhang Z, Yan C, Zhang S Mater Today Bio. 2025; 31:101476.

PMID: 39896290 PMC: 11787032. DOI: 10.1016/j.mtbio.2025.101476.

Systematic and comprehensive insights into HIF-1 stabilization under normoxic conditions: implications for cellular adaptation and therapeutic strategies in cancer.

Zhang J, Yao M, Xia S, Zeng F, Liu Q Cell Mol Biol Lett. 2025; 30(1):2.

PMID: 39757165 PMC: 11702238. DOI: 10.1186/s11658-024-00682-7.

Preclinical Assessment of Safety and Efficacy of Deferoxamine (DFO)-pretreated Feline Adipose Mesenchymal Stem Cells.

Teng H, Cho M, Ma Z, Ji X, Jin S, Zhou Y In Vivo. 2024; 39(1):267-279.

PMID: 39740892 PMC: 11705137. DOI: 10.21873/invivo.13825.

Resilience and challenges: Evaluating the impact of stress conditions on mesenchymal stem cells across different passages.

Ding Y, Lin F, Liang X World J Stem Cells. 2024; 16(11):974-977.

PMID: 39619876 PMC: 11606354. DOI: 10.4252/wjsc.v16.i11.974.

Preclinical Safety Assessment of Deferoxamine-preconditioned Canine Adipose Tissue-derived Mesenchymal Stem Cells.

Ji X, Zhang J, Jin S, Teng H, Zhou Y, Li X In Vivo. 2024; 38(6):2645-2655.

PMID: 39477396 PMC: 11535940. DOI: 10.21873/invivo.13741.

References

Saller M, Prall W, Docheva D, Schonitzer V, Popov T, Anz D . Increased stemness and migration of human mesenchymal stem cells in hypoxia is associated with altered integrin expression. Biochem Biophys Res Commun. 2012; 423(2):379-85. DOI: 10.1016/j.bbrc.2012.05.134. View

Fehrer C, Brunauer R, Laschober G, Unterluggauer H, Reitinger S, Kloss F . Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell. 2007; 6(6):745-57. DOI: 10.1111/j.1474-9726.2007.00336.x. View

Maki M, Koskenvuo J, Ukkonen H, Saraste A, Tuunanen H, Pietila M . Cardiac Function, Perfusion, Metabolism, and Innervation following Autologous Stem Cell Therapy for Acute ST-Elevation Myocardial Infarction. A FINCELL-INSIGHT Sub-Study with PET and MRI. Front Physiol. 2012; 3:6. PMC: 3277266. DOI: 10.3389/fphys.2012.00006. View

Ntege E, Sunami H, Shimizu Y . Advances in regenerative therapy: A review of the literature and future directions. Regen Ther. 2020; 14:136-153. PMC: 7033303. DOI: 10.1016/j.reth.2020.01.004. View

Osathanon T, Vivatbutsiri P, Sukarawan W, Sriarj W, Pavasant P, Sooampon S . Cobalt chloride supplementation induces stem-cell marker expression and inhibits osteoblastic differentiation in human periodontal ligament cells. Arch Oral Biol. 2014; 60(1):29-36. DOI: 10.1016/j.archoralbio.2014.08.018. View

Antebi B, Rodriguez 2nd L, Walker 3rd K, Asher A, Kamucheka R, Alvarado L . Short-term physiological hypoxia potentiates the therapeutic function of mesenchymal stem cells. Stem Cell Res Ther. 2018; 9(1):265. PMC: 6180371. DOI: 10.1186/s13287-018-1007-x. View

Ohnishi S, Yasuda T, Kitamura S, Nagaya N . Effect of hypoxia on gene expression of bone marrow-derived mesenchymal stem cells and mononuclear cells. Stem Cells. 2007; 25(5):1166-77. DOI: 10.1634/stemcells.2006-0347. View

Rosova I, Dao M, Capoccia B, Link D, Nolta J . Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells. 2008; 26(8):2173-82. PMC: 3017477. DOI: 10.1634/stemcells.2007-1104. View

Peyvandi A, Abbaszadeh H, Roozbahany N, Pourbakht A, Khoshsirat S, Niri H . Deferoxamine promotes mesenchymal stem cell homing in noise-induced injured cochlea through PI3K/AKT pathway. Cell Prolif. 2018; 51(2):e12434. PMC: 6528934. DOI: 10.1111/cpr.12434. View

10.

Duscher D, Januszyk M, Maan Z, Whittam A, Hu M, Walmsley G . Comparison of the Hydroxylase Inhibitor Dimethyloxalylglycine and the Iron Chelator Deferoxamine in Diabetic and Aged Wound Healing. Plast Reconstr Surg. 2017; 139(3):695e-706e. PMC: 5327844. DOI: 10.1097/PRS.0000000000003072. View

11.

Han S, Han S, Coh Y, Jang G, Ra J, Kang S . Enhanced proliferation and differentiation of Oct4- and Sox2-overexpressing human adipose tissue mesenchymal stem cells. Exp Mol Med. 2014; 46:e101. PMC: 4081551. DOI: 10.1038/emm.2014.28. View

12.

Yanas A, Liu K . RNA modifications and the link to human disease. Methods Enzymol. 2019; 626:133-146. PMC: 9074382. DOI: 10.1016/bs.mie.2019.08.003. View

13.

Pattappa G, Johnstone B, Zellner J, Docheva D, Angele P . The Importance of Physioxia in Mesenchymal Stem Cell Chondrogenesis and the Mechanisms Controlling Its Response. Int J Mol Sci. 2019; 20(3). PMC: 6387316. DOI: 10.3390/ijms20030484. View

14.

Liu X, Wang J, Ogle M, Wei L . Prolyl hydroxylase inhibitor dimethyloxalylglycine enhances mesenchymal stem cell survival. J Cell Biochem. 2009; 106(5):903-11. DOI: 10.1002/jcb.22064. View

15.

Raheja L, Genetos D, Yellowley C . The effect of oxygen tension on the long-term osteogenic differentiation and MMP/TIMP expression of human mesenchymal stem cells. Cells Tissues Organs. 2009; 191(3):175-84. DOI: 10.1159/000235679. View

16.

Hu X, Chen M, Dasgupta C, Xiao D, Huang X, Yang S . Chronic hypoxia upregulates DNA methyltransferase and represses large conductance Ca2+-activated K+ channel function in ovine uterine arteries. Biol Reprod. 2017; 96(2):424-434. PMC: 6366546. DOI: 10.1095/biolreprod.116.145946. View

17.

Liu S, He L, Yao K . The Antioxidative Function of Alpha-Ketoglutarate and Its Applications. Biomed Res Int. 2018; 2018:3408467. PMC: 5884300. DOI: 10.1155/2018/3408467. View

18.

Laksana K, Sooampon S, Pavasant P, Sriarj W . Cobalt Chloride Enhances the Stemness of Human Dental Pulp Cells. J Endod. 2017; 43(5):760-765. DOI: 10.1016/j.joen.2017.01.005. View

19.

Liehn E, Radu E, Schuh A . Chemokine contribution in stem cell engraftment into the infarcted myocardium. Curr Stem Cell Res Ther. 2013; 8(4):278-83. PMC: 3782704. DOI: 10.2174/1574888x11308040003. View

20.

Pattappa G, Thorpe S, Jegard N, Heywood H, de Bruijn J, Lee D . Continuous and uninterrupted oxygen tension influences the colony formation and oxidative metabolism of human mesenchymal stem cells. Tissue Eng Part C Methods. 2012; 19(1):68-79. DOI: 10.1089/ten.TEC.2011.0734. View